Armata Pharmaceuticals Inc.

ARMP | AMEX

Price Alert Chart Builder DCF Calculator

$4.26

+$0.08 (+1.91%)

At close: Sep 21, 2026, 4:00 PM ET

$4.15

-$0.11 (-2.58%)

Pre-market: Sep 22, 2026, 5:43 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-173.8M	-18.92M	-69.05M	-36.92M	-23.16M	-22.18M
Depreciation & Amortization	1.53M	1.33M	972K	892K	1.17M	1.11M
Stock-Based Compensation	2.61M	2.89M	938K	3.11M	2.88M	3.48M
Other Working Capital	-1.08M	1.66M	-9.69M	-4.28M	-979K	-951K
Other Non-Cash Items	145.31M	-20.75M	29.36M	n/a	-1.25M	196K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-1.41M	-2.1M	-9.65M	439K	-3.22M	-874K
Operating Cash Flow	-25.76M	-37.55M	-47.42M	-32.48M	-23.58M	-18.27M
Capital Expenditures	-542K	-1.88M	-8.14M	-2.21M	-1.3M	-824K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	10K	n/a	n/a	n/a
Investing Cash Flow	-542K	-1.88M	-8.13M	-2.21M	-1.3M	-824K
Debt Repayment	25M	34.89M	54.03M	n/a	n/a	717K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-46K	-61K	-43K	-500K	-801K	-400K
Financial Cash Flow	25.61M	34.96M	53.99M	44.02M	25.52M	23.21M
Net Cash Flow	-693K	-4.47M	-1.57M	4.56M	639K	4.12M
Free Cash Flow	-26.31M	-39.43M	-55.57M	-34.69M	-24.88M	-19.09M
Adj. Free Cash Flow	-28.92M	-42.32M	-56.51M	-37.8M	-27.76M	-22.57M
Maintenance CapEx	-542K	n/a	-8.14M	n/a	n/a	n/a
Growth CapEx	n/a	-1.88M	n/a	-2.21M	-1.3M	-824K
Owner Earnings	-26.31M	-37.55M	-55.57M	-32.48M	-23.58M	-18.27M